Eversept Partners as of Sept. 30, 2020
Portfolio Holdings for Eversept Partners
Eversept Partners holds 47 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corp Spons Adr New | 11.2 | $50M | 12M | 4.21 | |
| Horizon Therapeutics Pub L SHS | 10.5 | $47M | 608k | 77.68 | |
| Tg Therapeutics (TGTX) | 6.1 | $27M | 1.0M | 26.76 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.5 | $25M | 161k | 154.32 | |
| United Therapeutics Corporation (UTHR) | 5.4 | $24M | 241k | 101.00 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.8 | $22M | 2.4M | 9.01 | |
| Fate Therapeutics (FATE) | 4.8 | $21M | 535k | 39.97 | |
| Biohaven Pharmaceutical Holding | 4.7 | $21M | 322k | 65.01 | |
| Deciphera Pharmaceuticals | 4.6 | $21M | 402k | 51.30 | |
| Ensign (ENSG) | 4.1 | $18M | 319k | 57.11 | |
| Heska Corp Com Restrc New | 3.5 | $16M | 159k | 98.79 | |
| Zogenix Com New | 3.5 | $16M | 865k | 17.93 | |
| Catalent | 2.7 | $12M | 140k | 85.66 | |
| OraSure Technologies (OSUR) | 2.5 | $11M | 940k | 12.17 | |
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 2.3 | $10M | 2.7M | 3.88 | |
| D Fluidigm Corp Del (LAB) | 2.2 | $9.7M | 1.3M | 7.43 | |
| Qiagen Nv Shs New | 1.9 | $8.8M | 168k | 52.26 | |
| Taro Pharmaceutical Inds SHS (TARO) | 1.7 | $7.8M | 142k | 54.85 | |
| Danaher Corporation (DHR) | 1.5 | $6.8M | 31k | 215.50 | |
| Model N (MODN) | 1.5 | $6.7M | 189k | 35.28 | |
| Hca Holdings (HCA) | 1.5 | $6.5M | 52k | 124.68 | |
| Aurinia Pharmaceuticals (AUPH) | 1.4 | $6.4M | 436k | 14.73 | |
| Momenta Pharmaceuticals | 1.2 | $5.2M | 99k | 52.48 | |
| Mylan Nv Shs Euro | 1.1 | $4.8M | 325k | 14.83 | |
| Intra Cellular Therapies (ITCI) | 1.0 | $4.5M | 177k | 25.66 | |
| Affimed Therapeutics B V | 0.9 | $4.2M | 1.2M | 3.39 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $3.9M | 1.1M | 3.44 | |
| Oxford Immunotec Global Ord Shs | 0.8 | $3.4M | 293k | 11.70 | |
| Astrazeneca Sponsored Adr (AZN) | 0.7 | $3.3M | 61k | 54.80 | |
| Mersana Therapeutics | 0.6 | $2.6M | 140k | 18.62 | |
| Sanofi Sponsored Adr (SNY) | 0.6 | $2.5M | 50k | 50.17 | |
| Glaxosmithkline Sponsored Adr | 0.5 | $2.5M | 64k | 38.11 | |
| Apellis Pharmaceuticals (APLS) | 0.5 | $2.5M | 81k | 30.17 | |
| Celldex Therapeutics Com New (CLDX) | 0.5 | $2.2M | 151k | 14.83 | |
| Sesen Bio | 0.5 | $2.2M | 1.6M | 1.40 | |
| Quidel Corporation | 0.5 | $2.0M | 9.3k | 219.38 | |
| Prothena Corp SHS (PRTA) | 0.4 | $2.0M | 197k | 9.99 | |
| Otonomy | 0.4 | $1.7M | 413k | 4.05 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $1.4M | 107k | 12.59 | |
| Concert Pharmaceuticals I equity | 0.2 | $1.0M | 104k | 9.82 | |
| Liquidia Technologies (LQDA) | 0.2 | $899k | 183k | 4.92 | |
| Solid Biosciences (SLDB) | 0.1 | $623k | 307k | 2.03 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $611k | 36k | 16.83 | |
| Scpharmaceuticals (SCPH) | 0.1 | $489k | 66k | 7.45 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $266k | 1.9k | 140.43 | |
| Teligent Com New (TLGTQ) | 0.0 | $220k | 305k | 0.72 | |
| Gohealth Com Cl A | 0.0 | $171k | 13k | 13.03 |
